Journal Article

Sex and Gender Differences in Travel-Associated Disease

Patricia Schlagenhauf, Lin H. Chen, Mary E. Wilson, David O. Freedman, David Tcheng, Eli Schwartz, Prativa Pandey, Rainer Weber, David Nadal, Christoph Berger, Frank von Sonnenburg, Jay Keystone and Karin Leder

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 50, issue 6, pages 826-832
Published in print March 2010 | ISSN: 1058-4838
Published online March 2010 | e-ISSN: 1537-6591 | DOI:
Sex and Gender Differences in Travel-Associated Disease

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology


Show Summary Details


Background. No systematic studies exist on sex and gender differences across a broad range of travel-associated diseases.

Methods. Travel and tropical medicine GeoSentinel clinics worldwide contributed prospective, standardized data on 58,908 patients with travel-associated illness to a central database from 1 March 1997 through 31 October 2007. We evaluated sex and gender differences in health outcomes and in demographic characteristics. Statistical significance for crude analysis of dichotomous variables was determined using hi; 2 tests with calculation of odds ratios (ORs) and 95% confidence intervals (CIs). The main outcome measure was proportionate morbidity of specific diagnoses in men and women. The analyses were adjusted for age, travel duration, pretravel encounter, reason for travel, and geographical region visited.

Results. We found statistically significant (Pµ.001) differences in morbidity by sex. Women are proportionately more likely than men to present with acute diarrhea (OR, 1.13; 95% CI, 1.09–1.38), chronic diarrhea (OR, 1.28; 95% CI, 1.19–1.37), irritable bowel syndrome (OR, 1.39; 95% CI, 1.24–1.57), upper respiratory tract infection (OR, 1.23; 95% CI, 1.14–1.33); urinary tract infection (OR, 4.01; 95% CI, 3.34–4.71), psychological stressors (OR, 1.3; 95% CI, 1.14–1.48), oral and dental conditions, or adverse reactions to medication. Women are proportionately less likely to have febrile illnesses (OR, 0.15; 95% CI, 0.10–0.21); vector-borne diseases, such as malaria (OR, 0.46; 95% CI, 0.41–0.51), leishmaniasis, or rickettsioses (OR, 0.57; 95% CI, 0.43–0.74); sexually transmitted infections (OR, 0.68; 95% CI 0.58–0.81); viral hepatitis (OR, 0.34; 95% CI, 0.21–0.54); or noninfectious problems, including cardiovascular disease, acute mountain sickness, and frostbite. Women are statistically significantly more likely to obtain pretravel advice (OR, 1.28; 95% CI, 1.23–1.32), and ill female travelers are less likely than ill male travelers to be hospitalized (OR, 0.45; 95% CI, 0.42–0.49).

Conclusions. Men and women present with different profiles of travel-related morbidity. Preventive travel medicine and future travel medicine research need to address gender-specific intervention strategies and differential susceptibility to disease.

Journal Article.  1220 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.